Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the clinical utility of comprehensive medication monitoring using the Patient Medication Profile to improve heart failure patient medication therapy and associated outcomes relative to usual care in a hospital setting.


Clinical Trial Description

Congestive heart failure has an exceptionally high rate of hospital admission and is responsible for more readmissions (23.5% at 30 days) in the United States than the 2nd and 3rd leading causes combined. Inadequate medication reconciliation both on admission and discharge from the hospital is a significant cause of medical error. In one study of cardiovascular patients, 44% believed they were taking a medication they were not, and 96% were unable to recall at least one medication they were taking (1). In the same study patients omitted on average 6.8 medications from their medication list. Medication optimization through improved adherence and reconciled medical records has been postulated to significantly improve admission and 30-day hospital readmission rates (2).

Sano has developed a blood-based comprehensive medication monitoring tool that identifies and quantitates 235 prescription drugs and drug metabolites. It does not detect illicit drugs. This tool, which produces an output report designated the 'Patient Medication Profile', is designed to be used with clinical decision support to improve medication adherence, reduce medication errors, and optimize medication therapy. For heart failure patients, the investigators hypothesize that deploying the Patient Medication Profile with clinical decision support at key points of treatment intervention will A) improve medication adherence, B) identify and reconcile significant discrepancies in the medication list, C) result in reduced hospital admissions, and D) result in better overall patient outcomes. These outcome expectations are relative to usual care for heart failure patients.

1. Cumbler E, Wald H, Kutner J. J Hosp. Med. 2010 Feb; 5(2); 83-6

2. Gupta, Pankaj, et al. "Risk Factors for Nonadherence to Antihypertensive Treatment" Hypertension 69.6 (2017): 1113-1120. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03519477
Study type Interventional
Source Sano Informed Prescribing
Contact Scott Daniels
Phone 615-933-0900
Email scott@precera.com
Status Not yet recruiting
Phase N/A
Start date July 2018
Completion date September 2019